198 related articles for article (PubMed ID: 2697558)
21. Phenotypic heterogeneity in cultured skin fibroblasts from patients with disorders of peroxisome biogenesis belonging to the same complementation group.
Wiemer EA; Out M; Schelen A; Wanders RJ; Schutgens RB; Van den Bosch H; Tager JM
Biochim Biophys Acta; 1991 Oct; 1097(3):232-7. PubMed ID: 1718439
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of peroxisomal functions due to oxidative imbalance induced by mistargeting of catalase to cytoplasm is restored by vitamin E treatment in skin fibroblasts from Zellweger syndrome-like patients.
Kawada Y; Khan M; Sharma AK; Ratnayake DB; Dobashi K; Asayama K; Moser HW; Contreras MA; Singh I
Mol Genet Metab; 2004 Dec; 83(4):297-305. PubMed ID: 15589116
[TBL] [Abstract][Full Text] [Related]
23. Identification of a novel PEX14 mutation in Zellweger syndrome.
Huybrechts SJ; Van Veldhoven PP; Hoffman I; Zeevaert R; de Vos R; Demaerel P; Brams M; Jaeken J; Fransen M; Cassiman D
J Med Genet; 2008 Jun; 45(6):376-83. PubMed ID: 18285423
[TBL] [Abstract][Full Text] [Related]
24. Peroxisomal abnormality in fibroblasts from involved skin of CHILD syndrome. Case study and review of peroxisomal disorders in relation to skin disease.
Emami S; Rizzo WB; Hanley KP; Taylor JM; Goldyne ME; Williams ML
Arch Dermatol; 1992 Sep; 128(9):1213-22. PubMed ID: 1519936
[TBL] [Abstract][Full Text] [Related]
25. Animal cell mutants represent two complementation groups of peroxisome-defective Zellweger syndrome.
Shimozawa N; Tsukamoto T; Suzuki Y; Orii T; Fujiki Y
J Clin Invest; 1992 Nov; 90(5):1864-70. PubMed ID: 1430210
[TBL] [Abstract][Full Text] [Related]
26. Peroxisomal ghosts are intracellular structures distinct from lysosomal compartments in Zellweger syndrome: a confocal laser scanning microscopy study.
Santos MJ; Henderson SC; Moser AB; Moser HW; Lazarow PB
Biol Cell; 2000 Apr; 92(2):85-94. PubMed ID: 10879629
[TBL] [Abstract][Full Text] [Related]
27. Acyl-CoA oxidase, peroxisomal thiolase and dihydroxyacetone phosphate acyltransferase: aberrant subcellular localization in Zellweger syndrome.
van Roermund CW; Brul S; Tager JM; Schutgens RB; Wanders RJ
J Inherit Metab Dis; 1991; 14(2):152-64. PubMed ID: 1679469
[TBL] [Abstract][Full Text] [Related]
28. Genetic heterogeneity in the cerebrohepatorenal (Zellweger) syndrome and other inherited disorders with a generalized impairment of peroxisomal functions. A study using complementation analysis.
Brul S; Westerveld A; Strijland A; Wanders RJ; Schram AW; Heymans HS; Schutgens RB; van den Bosch H; Tager JM
J Clin Invest; 1988 Jun; 81(6):1710-5. PubMed ID: 2454948
[TBL] [Abstract][Full Text] [Related]
29. Characterization of human peroxisomal membrane proteins.
Santos MJ; Kawada ME; Espeel M; Figueroa C; Alvarez A; Hidalgo U; Metz C
J Biol Chem; 1994 Oct; 269(40):24890-6. PubMed ID: 7929170
[TBL] [Abstract][Full Text] [Related]
30. Biochemical and morphologic aspects of peroxisomes in the human rectal mucosa: diagnosis of Zellweger syndrome simplified by rectal biopsy.
Shimozawa N; Suzuki Y; Orii T; Yokota S; Hashimoto T
Pediatr Res; 1988 Dec; 24(6):723-7. PubMed ID: 3205629
[TBL] [Abstract][Full Text] [Related]
31. Different intracellular localization of peroxisomal proteins in fibroblasts from patients with aberrant peroxisome assembly.
Suzuki Y; Shimozawa N; Yajima S; Orii T; Yokota S; Tashiro Y; Osumi T; Hashimoto T
Cell Struct Funct; 1992 Feb; 17(1):1-8. PubMed ID: 1586963
[TBL] [Abstract][Full Text] [Related]
32. Pex3p-dependent peroxisomal biogenesis initiates in the endoplasmic reticulum of human fibroblasts.
Toro AA; Araya CA; Córdova GJ; Arredondo CA; Cárdenas HG; Moreno RE; Venegas A; Koenig CS; Cancino J; Gonzalez A; Santos MJ
J Cell Biochem; 2009 Aug; 107(6):1083-96. PubMed ID: 19479899
[TBL] [Abstract][Full Text] [Related]
33. Peroxisomal fatty acid beta-oxidation in relation to the accumulation of very long chain fatty acids in cultured skin fibroblasts from patients with Zellweger syndrome and other peroxisomal disorders.
Wanders RJ; van Roermund CW; van Wijland MJ; Schutgens RB; Heikoop J; van den Bosch H; Schram AW; Tager JM
J Clin Invest; 1987 Dec; 80(6):1778-83. PubMed ID: 3680527
[TBL] [Abstract][Full Text] [Related]
34. Nonspecific lipid transfer protein (sterol carrier protein-2) defective in patients with deficient peroxisomes.
Suzuki Y; Yamaguchi S; Orii T; Tsuneoka M; Tashiro Y
Cell Struct Funct; 1990 Oct; 15(5):301-8. PubMed ID: 2085845
[TBL] [Abstract][Full Text] [Related]
35. Presence of the peroxisomal 22-kDa integral membrane protein in the liver of a person lacking recognizable peroxisomes (Zellweger syndrome).
Lazarow PB; Fujiki Y; Small GM; Watkins P; Moser H
Proc Natl Acad Sci U S A; 1986 Dec; 83(23):9193-6. PubMed ID: 3538019
[TBL] [Abstract][Full Text] [Related]
36. Quantitative analysis of peroxisomal protein import in vitro.
Terlecky SR; Legakis JE; Hueni SE; Subramani S
Exp Cell Res; 2001 Feb; 263(1):98-106. PubMed ID: 11161709
[TBL] [Abstract][Full Text] [Related]
37. Identification and immunochemical characterization of a family of peroxisome membrane proteins (PMPs) in oilseed glyoxysomes.
Corpas FJ; Bunkelmann J; Trelease RN
Eur J Cell Biol; 1994 Dec; 65(2):280-90. PubMed ID: 7720723
[TBL] [Abstract][Full Text] [Related]
38. Occurrence of peroxisomal membrane proteins in methylotrophic yeasts grown under different conditions.
Sulter GJ; Looyenga L; Veenhuis M; Harder W
Yeast; 1990; 6(1):35-43. PubMed ID: 2316286
[TBL] [Abstract][Full Text] [Related]
39. Aberration in de novo ether lipid biosynthesis in peroxisomal disorders.
van den Bosch H; Schalkwijk CG; Schrakamp G; Wanders RJ; Schutgens RB; Schram AW; Tager JM
Prog Clin Biol Res; 1988; 282():139-50. PubMed ID: 3071794
[TBL] [Abstract][Full Text] [Related]
40. Complementation study of peroxisome-deficient disorders by immunofluorescence staining and characterization of fused cells.
Yajima S; Suzuki Y; Shimozawa N; Yamaguchi S; Orii T; Fujiki Y; Osumi T; Hashimoto T; Moser HW
Hum Genet; 1992 Mar; 88(5):491-9. PubMed ID: 1372585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
